Mouse anti Human CD44
![Research Use Only](static/images/certificates/ruo.jpg)
0441
ApplicationsFlow Cytometry
Product group Antibodies
ReactivityHuman
Overview
- SupplierNordic-MUbio
- Product NameMouse anti Human CD44
- Delivery Days Customer7
- ApplicationsFlow Cytometry
- Applications SupplierFlow Cytometry
- Category SupplierPrimary antibodies
- CertificationResearch Use Only
- Clone ID7F1
- ConcentrationSee vial for concentration
- HostMouse
- IsotypeIgG1
- Scientific DescriptionCD44
- Shelf life instructionSee expiration date on vial
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteCD44=Derived from the hybridization of mouse Sp2/0 myeloma cells with spleen cells from BALB/c mice immunized with TCR-gamma epsilon thymocytes
- Storage InstructionProduct should be stored at -20ºC. Aliquot to avoid freeze/thaw cycles
- UNSPSC12352203
References
- 1. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. Bazil V; Horejsi V J Immunol 1992 Aug 1;149(3):747-53 2. Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. Lesley J; He Q; Miyake K; Hamann A; Hyman R; Kincade PW J Exp Med 1992 Jan 1;175(1):257-66 3. Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages. Camp RL; Kraus TA; Pure E Cell Biol 1991 Dec;115(5):1283-92 4. Distinct effects of two CD44 isoforms on tumor growth in vivo. Sy MS; Guo YJ; Stamenkovic I J Exp Med 1991 Oct 1;174(4):859-66 5. Participation in normal immune responses of a metastasis-inducing splice variant of CD44 [see comments] Arch R; Wirth K; Hofmann M; Ponta H; Matzku S; Herrlich P; Zoller Comment in: Science 1992 Jul 31;257(5070):614 Science 1992 Jul 31;257(5070):682-5 6. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. Zlotnik A; Godfrey DI; Fischer M; Suda T J Immunol 1992 Aug 15;149(4):1211-5 7. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. Sy MS; Guo YJ; Stamenkovic I J Exp Med 1992 Aug 1;176(2):623-7